Automated Cord Blood Cell Viability and Concentration Measurements Using the Vi‑CELL XR
Stem cells, due to their differentiation into mature blood cells, are the key to successful bone marrow transplantation research. More recently, it has been found that umbilical cord blood is also a plentiful and rich source of hematopoietic stem cells.(1) Thus, both bone marrow and cord blood are used in treatment research of numerous cancers, immunological disorders, and certain genetic diseases.
Currently, many facilities provide parents the option to store, or bank, their newborn baby’s cord blood.(2) When cells are banked—usually in liquid nitrogen—two parameters must be accurately assayed. These measurements are cell concentration and percentage of cell viability.(3) These measurements are performed prior to storage and after the thawing process. Cells may decrease in both number and viability, mainly due to the cryopreservative employed in the freezing process (usually DMSO).
The Vi-CELL XR (Figure 1) automates the manual trypan blue vital dye exclusion method for cell viability determinations. In addition, the instrument provides an objective measurement of cellular concentration. As mentioned, these are two critical parameters required in the cord blood cell banking process. The objective of this work was to describe a method for cord blood sample preparation, and develop a cell type, accurate set of instrument parameters, for the Vi-CELL XR.
Materials and MethodsA sample of cord blood was obtained from Baptist Hospital, Miami, FL, by the SAS laboratory at Beckman Coulter. The blood was diluted 1:1 using room-temperature phosphate buffered saline. The standard Ficoll* gradient separation method was used to isolate the mononuclear cells.(4) Isolated cells were washed once in PBS and resuspended in 2 mL of Isoflow* (Isoton* II). A 1:10 dilution of the cell suspension was prepared by placing 100 µL of cells into 900 µL of Isoflow in a standard Vi-CELL™ sample cup. The Vi-CELL XR was used to develop the cord blood cell type. Prior to sample analysis, the Vi-CELL™ concentration control was assayed.
ResultsFigure 2 shows the results of the Vi-CELL concentration control. Figure 3 illustrates a cord blood cell image on the Vi-CELL XR. Figure 4 shows the cell type parameters used to analyze cord blood cells. The size range was set from 3 to 25 microns. Cell brightness: 85; cell sharpness: 100; viable cell spot brightness: 65; viable cell spot area: 5.
Cord blood stem cell infusions have significant advantages over bone marrow transplants. Viability and concentration of cord blood cells may be assayed using the Vi-CELL XR . The cell type settings for cord blood samples were determined. Size range 3 to 25 microns. Imaging parameters: Cell brightness: 85; cell sharpness: 100; viable cell spot brightness: 65; viable cell spot area: 5.
Figure 2. Results of the Vi-CELL concentration control.
Figure 3. A cord blood cell image on the Vi-CELL™ XR.
- Kurtzberg, J., Laughlin, M., Graham, M. L., et al. Placental blood as a source of hematopoietic stem cells for transplantation. Blood 90, 4665-4678 (1997).
- American Academy of Pediatrics Work Group on Cord Blood Banking. Cord blood banking for potential future transplantation: subject review. Pediatrics, Vol. 104, No. 11, 116- 118 (1999).
- Fiorino, Susan, Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center. Personal Communication.
- Boyum, A. Separation of white blood cells, Nature 204, 793-794 (1964).
Cell Counters, Sizers and Media Analyzers
Vi-CELL BLU Cell Viability Analyzer
- 21 CFR Part 11 Compliance with the Vi-CELL BLU Cell Viability Analyzer
- Vi-CELL BLU Cell Viability Analyzer Automation Integration
- Virtual Product Demonstration Request
- Vi-CELL BLU vs. Vi-CELL XR: Comparison of System Specifications
- Vi-CELL BLU Cell Analyzer Features
- Vi-CELL BLU Cell Viability Analyzer Software
- Cell Type Guidelines & Optimization
- Vi-CELL BLU Virtual Demonstration Video Gallery
- Vi-CELL MetaFLEX
- Vi-CELL XR Cell Viability Analyzer
- Multisizer 4e Coulter Counter
- Z Series Coulter Counter
- Multisizer 3 Coulter Counter
- Vi-CELL BLU Cell Viability Analyzer
- Applied Science
- Cell Types
- Disease Management
Biologics Drug Discovery and Development
- Analytical Method Development and Testing
- Biologics Assay Development
- Introduction to Biologics
- Target Discovery, Identification and Selection
- Biologics Drug Discovery
- Preclinical Drug Development
- Biologics Upstream Development
- Biologics Downstream Development
- cGMP Biologics Production
- QA / QC Release Testing
- Disease Research
- Reading Material
- Explore Your Industry
- European Pharmacopoeia EP 2.2.44
- ICH Q2
- IVDR 2022 is a marathon, not a sprint. We’ll help you go the distance.
- 21 CFR Part 11 - Data Integrity
- Maintaining Data Integrity: Understanding FDA ALCOA Guidance
- EU GMP Annex 1
- EU GMP Annex 11
- ISO 21501
- ISO Regulations
- Regulatory Entities: Separation with Cooperation
- USP 1046
- USP 1047
- USP , and EP2.9.19
- ISO 11171 Standard
- ISO 14644: Airborne Particulate Cleanliness in Cleanrooms and Clean Zones
- USP <787>
- Explore Resources For Your Sample Type
- Machine Learning Assisted Analysis for Cytometry Data
- Laser Diffraction for Particle Size Analysis
- Next Generation Sequencing
- Dynamic Light Scatter
- Dried Reagent Technology
- Accessible Flow
- Acoustic Liquid Handling Technology
- Acoustic Sample Management
- Fundamentals of Laboratory Automation
- Centrifugation Technology
- Cytobank Training
- Flow Cytometry
- SPRI Bead Technology
- Analytical Ultracentrifugation
- The Coulter Principle
- Use of Cells in Therapeutics Product Development
- Early Discovery Target ID
- Hit Generation and Selection
- Lead Optimization
- Quality Control for GMP Manufacturing
- Echo Liquid Handling for ADME-Tox
- Biologics Product Applications
- Enabling COVID-19 Research
- Echo Liquid Handling for Microsampling
- Process Development Manufacturing: Biotherapeutics
- Small Molecule Product Applications
- Techniques and Methods
- Research Areas